STVN STEVANATO GRP SPA

Stevanato Group to Present at Upcoming Investor Conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)--

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences.

The Company will participate in a fireside chat at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on Tuesday, November 12, 2024 at 11:00 a.m. (PT). The Company will also present at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 9:00 a.m. (GMT), and the Citi 2024 Global Healthcare Conference in Miami on Tuesday, December 3, 2024 at 1:45 p.m. (ET). A live webcast of each event will be available on the Company’s website at under the "Investors" section. Replays of the webcasts will be available for approximately 90 days after each event.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. To learn more, visit: .

EN
11/11/2024

Underlying

STVNSTEVANATO GRP SPA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STEVANATO GRP SPA

Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
GLW CORNING INC
GXI GERRESHEIMER AG ... (+3)

Sondierungsgespräche mit Private Equity – GXI in Transition

Mit Private Equity Investoren hätten lt. CN v 07.02.25 auf informeller und unverbindlicher Basis ihr „Interesse an einem möglichen öffentlichen Übernahmeangebot bekundet“. Interesse von Finanzinvestoren gab es bereits in der Vergangenheit. GXI ist in einer Übergangsphase, zumal die Bormioli-Integration andauert. Seit der Gewinnwarnung im 09/24 hatte sich der Aktienkurs fast halbiert.

GLW CORNING INC
GXI GERRESHEIMER AG
STVN STEVANATO GRP SPA
02/10/25 February 10, 2025 4 DE
Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 290.00
GLW CORNING INC
GXI GERRESHEIMER AG ... (+3)

Exploratory talks with private equity – GXI in transition

According to CN 07.02.25, private equity investors have expressed ‘interest in a potential public takeover offer’ on an informal and non-binding basis. GXI is in a transition phase, especially as the Bormioli integration is ongoing. There has been interest from financial investors in the past. Since the profit warning on 09/24, the share price has almost halved.

GLW CORNING INC
GXI GERRESHEIMER AG
STVN STEVANATO GRP SPA
02/10/25 February 10, 2025 4 EN
 PRESS RELEASE
Free
STVN STEVANATO GRP S...

Stevanato Group to Present at Upcoming Investor Conference

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the CJS Securities 25th Annual “New Ideas for the New Year” Investor Conference on Tuesday, January 14, 2025, at 8:00 a.m. ET. A live event webcast will be available on the Company’s website at under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event. About Stevanato Group Fou...

January 7, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 47.78
ANET Arista Networks...
WBA Walgreens Boots... ... (+48)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ANET ARISTA NETWORKS INC.
WBA WALGREENS BOOTS ALLIANCE INC
TSLA TESLA INC
TGTX TG THERAPEUTICS INC.
NVCR NOVOCURE LTD.
MXL MAXLINEAR INC
DAKT DAKTRONICS INC.
CIEN CIENA CORPORATION
JOUT JOHNSON OUTDOORS INC. CLASS A
AAOI APPLIED OPTOELECTRONICS INC.
GIII G-III APPAREL GROUP LTD.
FLXS FLEXSTEEL INDUSTRIES INC.
KINS KINGSTONE COS. INC.
SENEA SENECA FOODS CORP. CL A
RH RH
REVG REV GROUP INC.
STRT STRATTEC SECURITY CORP.
RIOT RIOT BLOCKCHAIN
AVGO BROADCOM INC.
ATOM ATOMERA
TARS TARSUS PHARMACEUTICALS
UPST UPSTART HOLDINGS
NOTV INOTIV INC
MRVL MARVELL TECHNOLOGY INC
QUBT QUANTUM COMPUTING INC
REE REE AUTOMOTIVE LTD
TASK TASKUS INC
VSCO VICTORIA'S SECRET & CO
ACHR ARCHER AVIATION INC
FINW FINWISE BANCORP
STVN STEVANATO GRP SPA
CRDO CREDO TECHNOLOGY GRP HLDG LTD
RGTI RIGETTI COMPUTING INC
OPFI OPPFI INC
COHR COHERENT CORP
ATGL ALPHA TECHNOLOGY GROUP LTD
BTSG BRIGHTSPRING HEALTH SERVICES INC.
AS AMER SPORTS INC.
ALAB ASTERA LABS INC
AIRJ MONTANA TECHNOLOGIES CORP
BKKT BAKKT HOLDINGS INC.
GRALV GRAIL INC.
RDDT REDDIT INC
SERV SERVE ROBOTICS INC
CDTX CIDARA THERAPEUTICS INC.
AMPL AMPLITUDE INC
LGCY LEGACY EDUCATION INC.
CCB CHASE CAPITAL VIII CAP SEC H 8.25%
12/16/24 December 16, 2024 1 EN
 PRESS RELEASE
Free
STVN STEVANATO GRP S...

Stevanato Group to Present at Upcoming Investor Conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences. The Company will participate in a fireside chat at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on Tuesday, November 12, 2024 at 11:00 a.m. (PT). The Company will also present at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 9:00 a.m. (GMT), and ...

November 11, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch